Nasdaq · Healthcare
GEOSPACE TECHNOLOGIES CORP (GEOS)
As-reported financials and recent SEC filings for GEOSPACE TECHNOLOGIES CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$110.8M
Net income
$-9.7M
Net margin
-8.8%
Diluted EPS
$-0.76
ROE
-7.7%
P/E (TTM)
—
Market cap
—
Debt / equity
0.0×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $110.8M | $135.6M | $124.5M | $89.3M | $75.9M |
| Gross profit | $32.9M | $52.6M | $51.7M | $18.0M | $-2.7M |
| Operating income | $-11.3M | $7.1M | $11.3M | $-23.1M | $-16.9M |
| Net income | $-9.7M | $-6.6M | $12.2M | $-22.9M | $-14.1M |
| Diluted EPS | $-0.76 | $-0.50 | $0.92 | $-1.76 | $-1.05 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-05-19
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →10-Q2026-05-08
View on EDGAR →8-K2026-05-07
View on EDGAR →SCHEDULE 13G2026-04-29
View on EDGAR →8-K2026-04-06
View on EDGAR →SCHEDULE 13G/A2026-03-26
View on EDGAR →SCHEDULE 13G/A2026-02-17
View on EDGAR →Largest Healthcare peers
Go deeper on GEOS
Search GEOSPACE TECHNOLOGIES CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.